10:00 am: When Innovation Outpaces Standardization-Solutions to Support Novel Wound Care Product Development
10:00 am – 11:00 am July 31, 2023
Join NAMSA as we discuss the components of customized test methods, the trend for regulatory bodies to demand even more clinically relevant In Vitro data and a review of case studies with real-world applications.
10:00 am: Webinar: The Chemical Characterization Puzzle: Is There a Solution?
10:00 am – 11:00 am August 2, 2023
Join NAMSA experts as they discuss the top chemical characterization challenges for today and how to address them. They will highlight many of the items that are seen in regulatory responses, both in the US and also from global agencies around the world.
Attendees can expect to walk away with a better understanding of designing material or chemical characterization studies with the best approach to generating data for global agencies, how device manufacturers can work with a laboratory to provide information, ensuring the best results for a study and identifying unknowns.
3:00 pm: WIB-National: Women Impacting STEM – Diversity in Careers in the Life Sciences
3:00 pm – 4:00 pm August 8, 2023
Are you a recent graduate embarking on an exciting journey in the world of life sciences? Or perhaps you’re an experienced professional seeking a mid-career change that aligns with your passion? Whether you’re determined to forge ahead on your current path or simply eager to explore the vast opportunities within the life sciences, we have an incredible event tailored just for you. Join us for this inspiring National Women In Bio Webinar featuring women making an impact in their fields. They’ll share their inspiring career journeys, revealing the invaluable insights and strategies they’ve acquired along the way.
10:00 am: Webinar: Infectious Disease Diagnostic Devices: The Move to at Home Testing and Treatment (Panel Discussion)
10:00 am – 11:00 am August 24, 2023
Join NAMSA as we discuss the future of at-home diagnostic testing with our panel of infectious disease experts. Our team will draw on their experience working for or with infectious disease industry leaders to pack up the following boxes:
Box 1: Looking at our past, would past pandemics have benefited from at home tests? What have we learned from COVID-19 that could be applied to this move?
Box 2: What must be packed up to support the “Big Move?” User environment, testing accuracy, pivotal trial design and global regulatory requirements (at a minimum) must to be considered.
Box 3: Should Infectious Disease Diagnostics move out of the care setting and into the home, just because it can? Our panel will discuss the pros and cons of the big move
Come see what the ACC Bioscience Incubator (ABI) has to offer to biotech startups. On Aug 31, ABI will host a webinar where Nancy Lyon, the Director, will share with you all that you need to know about how ABI can help your company reach its next level including: leasing space at ABI, what types of equipment and instrumentation is available, and how to apply.